SAO PAULO (Reuters) – The National Health Surveillance Agency (Anvisa) on Saturday determined the precautionary ban on batches of Chinese vaccine against Covid-19 CoronaVac, prohibiting the distribution and use of batches in a plant not approved in the emergency use authorization , said the regulator in a statement.
According to the statement, Anvisa was informed the day before by the Butantan Institute that Sinovac, the manufacturer of CoronaVac, sent to Brazil 25 batches in the vial-ampoule presentation (single dose and two doses), totaling 12,113,934 doses.
Read Also
- Ferrari: petrol divides Marko and Horner | FormulaPassion.it Sep 3, 2021
- Christmas: They Smell Good, But Are Scented Candles Safe for Indoor Air Quality? Dec 10, 2022
- The return of the pilots to Spa in the memory of Hubert | FormulaPassion.it Aug 26, 2021
- Users can permanently lose their Whatsapp account; understand Apr 14, 2021
- Pokémon Violet/Scarlet: new, legendary Pokémon, 4-player co-op, release date, the 9th generation is revealed in more detail Jun 1, 2022
- Energy renovation: A zero-rate loan coupled with MaPrimeRénov is launched Nov 17, 2022
- On iPad Pro M1, apps can only use 5GB of RAM May 28, 2021
